Clinical Trials Browser

Phase 1/2 × Recruiting × Axitinib × Clear all

NCT05808608 2025-01-27

A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma

Phase 1/2 Recruiting

Carcinoma, Renal Cell